Loading...
State‐of‐the‐art treatment of systemic lupus erythematosus
As glucocorticoids and immunosuppressive drugs are non‐specific therapeutic agents that cause many adverse reactions, the development of biologicals aiming to control specific molecular targets is anticipated for the treatment of systemic lupus erythematosus (SLE). The antibody targeting B cell‐acti...
Na minha lista:
| Udgivet i: | Int J Rheum Dis |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7187183/ https://ncbi.nlm.nih.gov/pubmed/32134201 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1756-185X.13817 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|